secwatch.observer — SEC 8-K summary
======================================

Issuer:     PETMED EXPRESS INC (PETS)
CIK:        0001040130
Form:       8-K
Filed at:   2025-02-10T23:59:59+00:00
Accession:  0001040130-25-000012
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PetMed Express Q3 net sales $53M; Adj. EBITDA rises to $2M from $0.9M
---------------------------------------------------------------------

- Net sales of $53.0 million in Q3 fiscal 2025.
- Gross margin rate 28.1%, up 80 bps from prior year.
- Adjusted EBITDA $2.0 million vs. $0.9 million prior year, a $1.1M improvement.
- G&A expenses reduced by $2.6 million year-over-year.
- CEO highlights transformation progress and operational efficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1040130/000104013025000012/0001040130-25-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1040130/000104013025000012/pets-20250210.htm
  HTML page:      https://secwatch.observer/filing/0001040130-25-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer